Nvidia stock falls after U.S. announces new restrictions on AI chip exports
- Nvidia and a number of other AI chip companies saw their shares fall Tuesday morning due to new U.S. export restrictions on China.
- These are a step up from previously announced export restrictions from the Biden administration.
- Nvidia has said the company does not expect an immediate material financial hit; however, it does expect a long-term dip in sales.
Nvidia and a number of other chipmakers saw shares fall Tuesday morning after the U.S. announced new restrictions on exports of artificial intelligence chips to China.
Shares of chip stocks have boomed in the last year due to the increased demand for AI products and services, which is powered by AI chips.
The new restrictions on exports to China are a step up from previously announced restrictions on artificial intelligence chips that the Biden administration had implemented over the last year.
Nvidia closed down 4.7%, and Broadcom closed down 2%. Marvell and Intel mostly recovered by the final bell, posting drops of 0.9% and 1.4%, respectively.
The new restrictions ban the sale of the slowed-down version of Nvidia chips, the H800 and A800, that were allowed to be exported to China under the old restrictions.
"The updates are specifically designed to control access to computing power, which will significantly slow the PRC's development of next-generation frontier model, and could be leveraged in ways that threaten the U.S. and our allies, especially because they could be used for military uses and modernization," U.S. Commerce Secretary Gina Raimondo said on a call with reporters.
Nvidia believes that the increased restrictions will not immediately lead to a material effect on its financial performance. However, the company expects a loss in sales in the longer term, according to a statement from August.
Don't miss these CNBC PRO stories:
- This bank just hiked its 1-year CD rate to a fresh high
- A low-cost way to protect against an S&P 500 drawdown as risks escalate
- How to invest $1 million for the next decade, according to private bankers and wealth advisors
- This highly profitable industry is booming as the population ages
- Bank of America sees risks for employers as insurance coverage of weight loss drugs grows